Nausea and vomiting: causes, clinical care, hydration and warning signs

Direct answer. Nausea means feeling the need to vomit, including without vomiting. Definition. Vomiting (emesis) expels stomach contents through the mouth. Definition. Assess the cause, hydration and warning signs. Confidence: moderate in these distinctions; independent comparative treatment benefit remains unresolved here.

Key takeaways
  • Describe nausea, actual vomiting, retching and food coming back up accurately.
  • Keep a timeline of episodes, medicines, associated symptoms and intake.
  • Repeated vomiting with inability to keep fluids down needs urgent assessment.
  • Blood, green vomit, severe pain, neurological changes or suspected poisoning needs prompt urgent or emergency help.
  • Pregnancy, childhood and existing fluid restrictions need individual care.
  • Symptom suppression and treatment of the cause are separate goals.

Table of contents

Evidence summary

Clinical guidance, human outcome research and funding independence answer different questions. The guidance below explains care; it does not independently reproduce the trials behind a medicine or supplement.

Claim / interventionEvidence reviewedFunding / conflictsInterpretation / limits
Symptom definitions and cause categoriesProvider and national clinical educationMixed provider receipts; expert/source-study interests unclosedDistinguish symptoms from a confirmed cause.
Cause and symptom careBounded patient-care contextPublic/provider review does not clear underlying trialsIndividual plan, no universal antiemetic course.
Rehydration and intakeCurrent national support/warningsWebsite finance separate from exact study allocationsNo universal quantity or restriction override.
Pregnancy/childrenDated obstetric and national pediatric warning contextSpecific dates and unresolved contributor interests disclosedCoordinated assessment; no adult regimen extrapolation.
Consumer productsNo eligible cause-independent cure establishedExact product/population finance and efficacy unresolvedNo laboratory mechanism adopted as benefit.

Nausea, retching and vomiting: use precise symptom descriptions

Retching means the movements of trying to vomit without bringing up stomach contents. Selected terminology. Tell the clinician what actually happens rather than using “being sick” for every sensation.

Describe whether food or fluid comes back up forcefully, whether there is mainly queasiness, and what you observe before and afterward. Do not assume a label from a search result identifies reflux, rumination or a vomiting syndrome. Those diagnoses need their own clinical assessment.

Record the onset, frequency and pattern in plain language. Explain whether this is a new illness, repeated separate episodes or an ongoing problem. Describe effects on eating, drinking, sleep, work or school rather than relying only on a numerical severity score.

An established diagnosis does not automatically explain a changed pattern. Tell the assessing team what differs from the usual episode. The useful starting point is a clear description of the present problem and the clinical question that remains unresolved.

Why nausea happens: digestive and non-digestive causes

Nausea can involve digestive, sensory, emotional and nervous-system processes. Selected mechanism context. A mechanism description is not proof of the cause in one individual.

Possible causes include infection, reflux, migraine, inner-ear conditions, pregnancy, motion sickness and medicines. Selected clinical differential. The other symptoms help clinical assessment, but a list cannot diagnose the illness.

Tell the team about headache, dizziness, pain, fever, bowel changes, chest symptoms and possible pregnancy. Give a dated travel or exposure history when relevant. If others became unwell after a shared meal, describe that without deciding which organism or treatment is responsible.

Ask whether a suspected explanation is confirmed or provisional and what would prompt reconsideration. Anxiety or a previous functional disorder should not become an automatic explanation for every new concern. Assessment should address the actual symptoms and warning signs rather than one familiar label.

Cause-focused care, antiemetic medicines and treatment goals

A clinician may prescribe anti-sickness medicine after assessment. Selected care context. This guide gives no drug, dose, combination, route or duration.

Ask what each intervention is intended to do: reduce a symptom, correct fluid loss, treat an established disease or support intake while investigation continues. A temporary reduction in vomiting does not necessarily settle the original diagnostic question.

Request instructions for incomplete relief, adverse effects and inability to retain prescribed medicines. Ask whom to contact rather than automatically repeating a dose or adding another product. A single clear plan is especially useful when several teams or prescriptions are involved.

For recurring episodes, discuss whether a condition-specific plan is needed and how it should be reassessed if the pattern changes. This article does not select a chronic-vomiting diagnosis, certify an outpatient plan or provide a universal emergency-medication sequence.

Hydration, food and supplements: practical support with limits

NHS dehydration information describes pharmacist-assisted oral rehydration care for fluid losses. Selected current support context. Ask which plan fits your circumstances; there is no universal drink quantity or homemade solution recipe here.

Explain what food and fluid can be retained, whether intake is worsening and whether there has been unintentional weight loss. Tell the team about existing heart, kidney or liver restrictions. Request coordinated advice rather than interpreting “drink plenty” as permission to override an established fluid plan.

No independent cause-independent ginger, peppermint, probiotic, vitamin or herbal-product cure is established in this review. A food recommendation, an exact supplement and treatment of a specific diagnosis are different claims. Ask which human population and meaningful outcomes support a proposed product.

Bring labels to the clinician or pharmacist. NCCIH supports discussing supplements and medicine interactions with professionals. Generic dated safety context. No formulation is cleared here, and a reassuring natural-product label should not delay assessment of serious vomiting.

History, examination and targeted investigation

Frequent nausea that disrupts life or adequate intake needs clinical review. Selected assessment context. Ask what investigation is appropriate to the pattern rather than requesting every available digestive test.

Bring a concise timeline of episodes, associated symptoms, medicines, previous investigations and relevant procedures. Record whether symptoms started before or after a treatment change. Actual reports are more useful than a summary that previous tests were “normal.”

Ask what the examination or test is intended to establish, what it cannot answer and how the result could change care. A recurring symptom does not automatically require a repeat scan; an earlier reassuring result also does not settle every new illness.

Before testing, follow the actual service’s instructions about preparation and medicines. Disclose pregnancy or its possibility, relevant allergies and other medical conditions. This guide supplies no fasting interval, antimicrobial washout, imaging clearance or personal medicine interruption.

Emergency blood, green vomit, severe pain and neurological changes

Green vomit, sudden severe abdominal pain or headache, neck stiffness with light sensitivity, confusion or severe breathing difficulty needs emergency help. Persistent vomiting with inability to retain fluids needs urgent assessment. Selected national warnings.

Vomiting blood always requires medical help; with faintness, confusion, rapid breathing, clammy skin, abdominal pain or black stool, seek emergency help. Selected current bleeding warnings. A small amount or temporary stopping does not establish the cause.

Vomiting after a head injury needs emergency assessment. Selected current warning. Do not attribute a new neurological concern to a familiar stomach illness.

Sudden nausea with heavy chest pain, spreading pain or breathlessness can signal a cardiac emergency. Selected cardiac warning. Seek help without first proving whether the symptom is digestive. Describe what changed and bring readily available medicine information without delaying care.

Medicine review, harmful exposures and no induced vomiting

Medicines or recent surgery may contribute to nausea. Selected history context. Provide the complete prescription, nonprescription and supplement list, with recent changes. A temporal association needs interpretation rather than automatic attribution.

Ask the relevant prescriber and assessing clinician to coordinate any change. Do not independently stop, taper or replace a necessary prescription. Discuss what to do if it cannot be retained, and request clear instructions for any planned investigation or procedure.

Suspected poisoning needs immediate professional help. Do not try to induce vomiting after a potentially harmful ingestion; it can cause choking. Selected current emergency context. No antidote or charcoal regimen is provided.

Tell the receiving service what may have been swallowed, inhaled or encountered and bring packaging when practical. Do not wait for symptoms to prove an exposure harmless. This guide does not provide a poison-dose threshold, a home decontamination technique or clearance based on temporary improvement.

Pregnancy, babies, children and other vulnerable circumstances

Severe pregnancy sickness can prevent adequate intake and may need hospital care. Frequent vomiting or inability to keep food down warrants prompt contact with the midwife or doctor. Selected dated obstetric context. There is no universal pregnancy-safe medicine or supplement clearance here.

A baby or child who stops feeding or shows dehydration needs urgent pediatric advice. Selected age-specific warning. Adult medicine and fluid instructions are not a pediatric regimen.

Reduced urine or persistent dizziness can require urgent dehydration review. Confusion, difficulty waking or breathing problems may signal severe deterioration needing emergency help. Selected current warning context.

Tell the team about frailty, immune conditions and major heart, kidney or liver illness. Ask who coordinates intake support and medicine review with existing care. This article gives no admission threshold, feed-concentration change or outpatient eligibility rule for these circumstances.

Repeated episodes, nutritional effects and follow-up

Repeated vomiting can contribute to dehydration, nutritional problems and unexpected weight loss. Selected consequence context. Ask what assessment and support are needed when symptoms interfere with intake.

Keep the episode pattern and the impact on daily life in a concise record. Bring any established vomiting-syndrome plan and explain whether it still matches the present symptoms. Request a review if the pattern, associated concerns or ability to retain treatment changes.

Agree who communicates pending results, reviews the response and provides advice between appointments. Ask what to do if an expected appointment or result does not arrive. Discharge and symptom improvement are different from confirmation that the underlying question has been resolved.

If symptoms persist despite treatment, ask whether further diagnostic review, medicine tolerability assessment or nutritional support is needed. The next step should answer the unresolved problem rather than automatically extending a remedy or assuming every recurrence has the same explanation.

Independent evidence, product claims and laboratory studies

Confidence is moderate in the selected symptom distinctions, assessment principles and safety categories. No independent cause-independent treatment comparison is established here. A guide to vomiting cannot determine a universal drug, diet or supplement plan for its many possible causes.

Provider and public patient education can organize clinical discussion, but institutional authority does not clear exact contributor or source-study finances. Some selected national pregnancy guidance has passed its stated review date; the date and limited role are disclosed.

For a proposed intervention, ask about the confirmed diagnosis, human population, comparator, meaningful symptom/function outcomes, adverse effects and full financial declarations. A remedy investigated for one specific setting should not be generalized to every episode of nausea or vomiting.

Corporate-sponsored and developer-produced efficacy is excluded from the independent verdict. Animal, cell and receptor hypotheses cannot establish a safe human product, antiemetic regimen or cure. Evaluate the treatment evidence for an actual diagnosed condition separately from general symptom education.

Funding and source roles

Follow the money

Who paid for the evidence?

Follow named sources to the funding and relationships disclosed in this article. Numbered article disclosures preserve notes where a source is not identified. A public or university name alone does not establish independence.

Public / academicCommercial support or tiesUnknown / not disclosed
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsB, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Disclosed funding & relationshipsInstitutional writing and expert-review process; mixed provider funds above, no individual reviewer-payment ledger.
Use & limitsB, provisional — actual policy describes professional writers and medical-expert review. Accuracy incentive is credible; an institutional perspective and unverified individual conflicts remain.
Disclosed funding & relationshipsMixed provider receipts; accounts, ads and editorial profiles separate. Expert/page and source-study interests unclosed.
Use & limitsC, provisional — actual body/date read. Clinical review helps; selected misleading generalizations and unclosed trial finance limit use.
View 11 more funding disclosures
Disclosed funding & relationshipsMixed provider receipts; accounts, ads and editorial profiles separate. Expert/page and source-study interests unclosed.
Use & limitsC, provisional — actual body/date read. Clinical review helps; selected misleading generalizations and unclosed trial finance limit use.
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsB, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Source / disclosureNHS: dehydration, 1 May 2026
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsB, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsB, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Source / disclosureNHS: poisoning, 12 June 2025
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsB, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Disclosed funding & relationshipsNational website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.
Use & limitsC, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
Disclosed funding & relationshipsOwn policy states DHSC website funding and no advertising or corporate sponsorship; staff outside interests should be declared. Actual payments and current implementation not audited.
Use & limitsC, provisional — actual 14 October 2022 policy read; 14 October 2025 review deadline passed. Stated accountability aids provenance, but dated organization names and declaration implementation remain gaps.
Disclosed funding & relationshipsProvider statutory report; externally audited by EY. Patient/payer revenue, advisory services, research grants, corporate/foundation/individual pledges and investments.
Use & limitsB, provisional — issued 9 March 2026, complete 75-page original accessed and relevant notes read. Audit concerns the accounts, not this article or intervention trials.
Disclosed funding & relationshipsSite accepts advertising/sponsor revenue; provider retains content/placement approval and states editorial separation.
Use & limitsB, provisional — policy itself read; January 2020 guidelines state they can change. Actual page advertiser amounts and compliance not independently audited.
Disclosed funding & relationshipsFederal budget original identifies public support; actual page allocation and every cited product study unclosed.
Use & limitsC, provisional — actual body/date January 2019, with some later references. Federal safety review helps; dated synthesis and unclosed product-study finance do not establish symptom/product benefit.
Disclosed funding & relationshipsNIH/HHS federal congressional-budget documentation. Requested-year budgets and institutional priorities do not establish the finance of every cited supplement trial.
Use & limitsB, provisional — traceable government-budget process; an older fiscal document and incomplete page/trial donor chain.

This graphic reorganizes the article's disclosures; it is not a new financial audit or independence classification. Highlighted notes show different funding relationships where available. Review funding is separate from underlying trial funding. Disclosure is not proof of falsehood, and no declared conflict is not proof of complete independence.

National website finance, provider accounts and the exact interests behind clinical studies are separate questions. The profiles preserve actual dates, documented institutional routes and unresolved page/expert allocations. No branded clinical source is treated as automatic independent treatment evidence.

SourceFunding / backersCountry / jurisdictionIndependenceCredibility / incentives / gaps
Cleveland Clinic: nausea, 17 September 2025Mixed provider receipts; accounts, ads and editorial profiles separate. Expert/page and source-study interests unclosed.United States; Cleveland Clinic, Cleveland, Ohio.Tier 2 provider context, provisional.C, provisional — actual body/date read. Clinical review helps; selected misleading generalizations and unclosed trial finance limit use.
Cleveland Clinic: vomiting, 17 September 2025Mixed provider receipts; accounts, ads and editorial profiles separate. Expert/page and source-study interests unclosed.United States; Cleveland Clinic, Cleveland, Ohio.Tier 2 provider context, provisional.C, provisional — actual body/date read. Clinical review helps; selected misleading generalizations and unclosed trial finance limit use.
NHS: nausea, 17 November 2023National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.B, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: diarrhea and vomiting, 21 December 2023National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.B, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: dehydration, 1 May 2026National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.B, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: vomiting blood, 18 August 2025National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.B, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: poisoning, 12 June 2025National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.B, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: severe pregnancy vomiting, 11 January 2023National website policy separately profiled; exact contributors, page allocation and source-study finance unclosed.United Kingdom; national website, not provider-trust finance.Tier 2 public context, provisional.C, provisional — actual dated full body read. Public clinical review helps; supporting-trial financial chains unclosed.
NHS: October 2022 content and funding policyOwn policy states DHSC website funding and no advertising or corporate sponsorship; staff outside interests should be declared. Actual payments and current implementation not audited.United Kingdom; national NHS website; historical policy names NHS Digital, not asserted as the present institutional structure.Tier 3 institutional editorial/financial self-disclosure.C, provisional — actual 14 October 2022 policy read; 14 October 2025 review deadline passed. Stated accountability aids provenance, but dated organization names and declaration implementation remain gaps.
Cleveland Clinic: original audited 2025/2024 accountsProvider statutory report; externally audited by EY. Patient/payer revenue, advisory services, research grants, corporate/foundation/individual pledges and investments.United States; Cleveland Clinic Health System, Cleveland, Ohio.Tier 3 provider financial self-report with external audit.B, provisional — issued 9 March 2026, complete 75-page original accessed and relevant notes read. Audit concerns the accounts, not this article or intervention trials.
Cleveland Clinic: advertising policySite accepts advertising/sponsor revenue; provider retains content/placement approval and states editorial separation.United States; Cleveland, Ohio.Tier 3 own commercial-policy disclosure.B, provisional — policy itself read; January 2020 guidelines state they can change. Actual page advertiser amounts and compliance not independently audited.
Cleveland Clinic: editorial policyInstitutional writing and expert-review process; mixed provider funds above, no individual reviewer-payment ledger.United States; Cleveland, Ohio.Tier 3 own process disclosure.B, provisional — actual policy describes professional writers and medical-expert review. Accuracy incentive is credible; an institutional perspective and unverified individual conflicts remain.
NCCIH: using dietary supplements wiselyFederal budget original identifies public support; actual page allocation and every cited product study unclosed.United States; NIH/NCCIH, Bethesda, Maryland; credited internal 2019 reviewers D. Craig Hopp and David Shurtleff.Tier 1 public institution, provisional; source-trial finance unclassified.C, provisional — actual body/date January 2019, with some later references. Federal safety review helps; dated synthesis and unclosed product-study finance do not establish symptom/product benefit.
NCCIH: own congressional-budget documentNIH/HHS federal congressional-budget documentation. Requested-year budgets and institutional priorities do not establish the finance of every cited supplement trial.United States; NCCIH, Bethesda, Maryland.Tier 1 public institution; budget self-report context.B, provisional — traceable government-budget process; an older fiscal document and incomplete page/trial donor chain.

Frequently asked questions

Can nausea happen without vomiting?

Yes. Describe the actual sensation and whether anything is brought up.

Does vomiting always mean food poisoning?

No. Give the full symptom and exposure history so the clinician can assess the explanation.

Should I automatically repeat a medicine after vomiting?

Ask the prescriber or pharmacist for an instruction specific to the medicine and situation.

Can a ginger supplement replace assessment?

No independent cause-independent product cure is established here; serious symptoms require care.

What if I cannot keep fluids down?

Seek urgent assessment rather than relying on a universal drink recipe or waiting period.

What if the usual episode pattern changes?

Contact the responsible clinician and describe the change; an old diagnosis is not permanent clearance.

Sources and funding notes

Originals checked 4 October 2026. Actual provider September2025 nausea/vomiting and national November2023 nausea, December2023 diarrhea/vomiting, May2026 dehydration, August2025 bleeding, June2025 poisoning and January2023 obstetric bodies read. Pregnancy page passed January2026 review due. Source-derived content is bounded across repeated sections/profiles. Provider OTC-classification, Barrett-causation, generic reassurance, fixed waiting and home-regimen statements are not adopted. No drug/feeding/fluid schedule, homemade rehydration recipe, induced vomiting or universal pregnancy clearance is supplied. This is a related clinical symptom guide.

  1. Cleveland Clinic: nausea, 17 September 2025 — Symptom definition/multiple systems; OTC classification and broad reassurance excluded.
  2. Cleveland Clinic: vomiting, 17 September 2025 — Definition, consequence and head-injury warning; Barrett-causation and numeric waiting rules excluded.
  3. NHS: nausea, 17 November 2023 — Selected cause/treatment and cardiac-warning context; no universal herbal recommendation.
  4. NHS: diarrhea and vomiting, 21 December 2023 — Urgent vomiting/infection context; no personal fluid, feeding or work-exclusion timetable.
  5. NHS: dehydration, 1 May 2026 — Selected urgent deterioration and clinical rehydration context.
  6. NHS: vomiting blood, 18 August 2025 — Urgent bleeding assessment, not a home cause diagnosis.
  7. NHS: poisoning, 12 June 2025 — Immediate professional help and no induced vomiting; no charcoal/antidote regimen.
  8. NHS: severe pregnancy vomiting, 11 January 2023 — Prompt obstetric review; January 2026 review deadline passed.
  9. NHS: October 2022 content and funding policy — October 2022 national website funding policy; October 2025 review due passed, provider trusts separate.
  10. Cleveland Clinic: original audited 2025/2024 accounts — Actual audited 2025/2024 provider income; no symptom-page allocation.
  11. Cleveland Clinic: advertising policy — January 2020 advertising policy; implementation unclosed.
  12. Cleveland Clinic: editorial policy — Editorial process; no complete individual or trial finance clearance.
  13. NCCIH: using dietary supplements wisely — January 2019 generic safety; no cause-independent symptom product cure.
  14. NCCIH: own congressional-budget document — Federal budget request, not current receipts or efficacy clearance.

Educational information reviewed 4 October 2026. This guide supports an informed clinical discussion; it does not diagnose an individual or provide a personal treatment regimen.

Have a question — or want us to cover something?

Ask about anything on this page, or request the next deep dive: an ingredient, a supplement, or a health concern. We use published research, evidence syntheses, and regulatory guidance, with clear source links.

We store your topic, message, optional email, and this page so we can manage and reply to the request. Do not include diagnoses, medications, or other sensitive medical information. See our Privacy Policy.